Insiders · PSTX

PSTX insider transactions

Poseida Therapeutics Inc. (PSTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for PSTX

• 513d
  Large owner Malin Life Sciences Holdings Ltd closing all direct ownership in the company (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 515d
  Director Amado Rafael closing all direct ownership in the company (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 515d
  Director Corning Luke closing all direct ownership in the company (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 515d
  Director Schmid John P. closing all direct ownership in the company (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 515d
  Director Lloyd Marcea Bland closing all direct ownership in the company (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 515d
  Director Collins Cynthia closing all direct ownership in the company (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 515d
  Director Baum Charles M closing all direct ownership in the company (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 515d
  Chief Financial Officer Mylet Johanna closing all direct ownership in the company (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 515d
  GC & Chief Compliance Officer Leonhardt Harry J closing all direct ownership in the company (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 515d
  Chief Medical Officer Rizvi Syed Ali-Aamir closing all direct ownership in the company (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 515d
  President and CEO Gergen Mark J closing all direct ownership in the company (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 515d
  President and CEO Yarema Kristin closing all direct ownership in the company (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 520d
  Executive Chairman Gergen Mark J covered exercise/tax liability with 23,313 shares, decreasing direct ownership by 4% to 630,726 units (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 543d
  Executive Chairman Gergen Mark J exercised 30,000 shares at a strike of $2.78 and sold $283,866 worth of shares (30,000 units at $9.46) (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 557d
  Executive Chairman Gergen Mark J exercised 30,000 shares at a strike of $2.78 and sold $278,100 worth of shares (30,000 units at $9.27) (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 719d
  Director Schmid John P. was granted 19,650 shares, increasing direct ownership by 50% to 58,950 units (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 719d
  Director Lloyd Marcea Bland was granted 19,650 shares, increasing direct ownership by 40% to 68,950 units (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 719d
  Director Corning Luke was granted 19,650 shares, increasing direct ownership by 50% to 58,950 units (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 719d
  Director Collins Cynthia was granted 19,650 shares, increasing direct ownership by 50% to 58,950 units (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 719d
  Director Baum Charles M was granted 19,650 shares, increasing direct ownership by 33% to 78,600 units (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 719d
  Director Amado Rafael was granted 19,650 shares, increasing direct ownership by 50% to 58,950 units (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 795d
  Rizvi Syed Ali-Aamir was granted 185,000 shares (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 795d
  SEC Form 3 filed by new insider Rizvi Syed Ali-Aamir

  3 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 825d
  Mylet Johanna was granted 80,743 shares and covered exercise/tax liability with 18,091 shares, increasing direct ownership by 34% to 246,283 units (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 825d
  Warner Brent was granted 80,743 shares and covered exercise/tax liability with 35,739 shares, increasing direct ownership by 12% to 419,040 units (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 825d
  Leonhardt Harry J was granted 80,743 shares and covered exercise/tax liability with 16,306 shares, increasing direct ownership by 43% to 214,640 units (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 825d
  Gergen Mark J covered exercise/tax liability with 34,157 shares, decreasing direct ownership by 5% to 651,291 units (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 856d
  Gergen Mark J covered exercise/tax liability with 47,162 shares, decreasing direct ownership by 6% to 685,448 units (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 885d
  Yarema Kristin was granted 250,000 shares, increasing direct ownership by 70% to 606,836 units (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 885d
  Gergen Mark J was granted 125,000 shares, increasing direct ownership by 21% to 732,610 units (SEC Form 4)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1087d
  SEC Form 4 filed by Collins Cynthia

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1087d
  SEC Form 4 filed by Schmid John P.

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1087d
  SEC Form 4 filed by Lloyd Marcea Bland

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1087d
  SEC Form 4 filed by Baum Charles M

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1087d
  SEC Form 4 filed by Corning Luke

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1132d
  SEC Form 4 filed by Amado Rafael

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1150d
  SEC Form 3 filed by new insider Amado Rafael

  3 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1152d
  SEC Form 4 filed by Yarema Kristin

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1152d
  SEC Form 3 filed by new insider Yarema Kristin

  3 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1193d
  SEC Form 4: Warner Brent was granted 92,772 shares and covered exercise/tax liability with 26,617 shares, increasing direct ownership by 21% to 374,036 units (for withholding tax)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1193d
  SEC Form 4: Mylet Johanna was granted 92,772 shares and covered exercise/tax liability with 4,323 shares, increasing direct ownership by 99% to 177,631 units (for tax liability)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1193d
  SEC Form 4: Leonhardt Harry J was granted 92,772 shares and covered exercise/tax liability with 4,323 shares, increasing direct ownership by 159% to 144,203 units (for tax liability)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1193d
  SEC Form 4: Gergen Mark J was granted 269,586 shares, increasing direct ownership by 81% to 601,610 units

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1220d
  SEC Form 4: Ostertag Eric covered exercise/tax liability with 11,776 shares, decreasing direct ownership by 1% to 827,320 units (tax withholding)

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1220d
  SEC Form 4: Gergen Mark J covered exercise/tax liability with 31,819 shares, decreasing direct ownership by 9% to 330,314 units to satisfy withholding tax

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1237d
  SEC Form 5 filed by Ostertag Eric

  5 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1397d
  SEC Form 4: Malin Life Sciences Holdings Ltd bought $7,525,000 worth of shares (2,150,000 units at $3.50), increasing direct ownership by 22% to 11,835,673 units

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1397d
  SEC Form 4: Ostertag Eric bought $500,000 worth of shares (142,857 units at $3.50), increasing direct ownership by 21% to 838,824 units

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1402d
  SEC Form 4: Ostertag Eric sold $592,808 worth of shares (160,696 units at $3.69) as part of a pre-agreed trading plan

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1452d
  SEC Form 4: Collins Cynthia was granted 19,650 shares

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1452d
  SEC Form 4: Baum Charles M was granted 39,300 shares

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1452d
  SEC Form 4: Corning Luke was granted 19,650 shares

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1452d
  SEC Form 4: Schmid John P. was granted 19,650 shares

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1452d
  SEC Form 4: Lloyd Marcea Bland was granted 19,650 shares, increasing direct ownership by 196% to 29,650 units

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1481d
  SEC Form 3 filed by new insider Baum Charles M

  3 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1542d
  SEC Form 4: Ingalls Kerry D. bought $11,940 worth of shares (3,000 units at $3.98), increasing direct ownership by 6% to 55,000 units

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1559d
  SEC Form 4: Mylet Johanna was granted 50,000 shares, increasing direct ownership by 146% to 84,231 units

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1559d
  SEC Form 4: Warner Brent was granted 307,881 shares

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1559d
  SEC Form 4: Ingalls Kerry D. was granted 50,000 shares, increasing direct ownership by 2,500% to 52,000 units

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)
• 1559d
  SEC Form 4: Leonhardt Harry J was granted 50,000 shares

  4 - Poseida Therapeutics, Inc. (0001661460) (Issuer)